Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2017-04-21

First medicine for spinal muscular atrophy

View source ↗

Summary

EMA announces the first medicine approved for spinal muscular atrophy, marking a milestone in treatment for this disease in Europe.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications